Raffaella Soldi

Years Active: 2020-2023
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Atish Mohanty, Arin Nam, Saumya Srivastava, Jeffrey J Jones, Brett Lomenick, Sharad S Singhal, Linlin Guo, Hyejin Cho, Aimin Li, Amita Behal, Tamara Mirzapoiazova, Erminia Massarelli, Marianna Koczywas, Leonidas D Arvanitis, Tonya Walser, Victoria Villaflor, Stanley R Hamilton, Isa Mambetsariev, Martin Sattler, Mohd Wasim Nasser, Maneesh Jain, Surinder Kumar Batra, Raffaella Soldi, Sunil Sharma, Marwan G Fakih, Saswat Kumar Mohanty, Avijit Mainan, Xiwei Wu, Yihong Chen, Yanan He, Tsui-Fen Chou, Susmita Roy, John Orban, Prakash Kulkarni, Ravi Salgia
Acquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancer. Science advances 9 (41) (2023)
Raffaella Soldi, Tithi Ghosh Halder, Alexis Weston, Trason Thode, Kevin Drenner, Rhonda Lewis, Mohan R Kaadige, Shreyesi Srivastava, Sherin Daniel Ampanattu, Ryan Rodriguez Del Villar, Jessica D Lang, Hariprasad Vankayalapati, Bernard Weissman, Jeffrey M Trent, William P D Hendricks, Sunil Sharma
The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancer. PloS one 15 (7) (2020)

Raffaella Soldi.css-eqlu8i{font-size:small;padding-left:4px;}